Suppr超能文献

双硫仑:作用机制、应用及挑战

Disulfiram: Mechanisms, Applications, and Challenges.

作者信息

Lanz Jenna, Biniaz-Harris Nicholas, Kuvaldina Mara, Jain Samta, Lewis Kim, Fallon Brian A

机构信息

Lyme & Tick-Borne Diseases Research Center, Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, Columbia University, New York, NY 10032, USA.

Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, MA 02115, USA.

出版信息

Antibiotics (Basel). 2023 Mar 6;12(3):524. doi: 10.3390/antibiotics12030524.

Abstract

: Since disulfiram's discovery in the 1940s and its FDA approval for alcohol use disorder, other indications have been investigated. This review describes potential clinical applications, associated risks, and challenges. : For this narrative review, a PubMed search was conducted for articles addressing in vivo studies of disulfiram with an emphasis on drug repurposing for the treatment of human diseases. The key search terms were "disulfiram" and "Antabuse". Animal studies and in vitro studies highlighting important mechanisms and safety issues were also included. : In total, 196 sources addressing our research focus spanning 1948-2022 were selected for inclusion. In addition to alcohol use disorder, emerging data support a potential role for disulfiram in the treatment of other addictions (e.g., cocaine), infections (e.g., bacteria such as Staphylococcus aureus and Borrelia burgdorferi, viruses, parasites), inflammatory conditions, neurological diseases, and cancers. The side effects range from minor to life-threatening, with lower doses conveying less risk. Caution in human use is needed due to the considerable inter-subject variability in disulfiram pharmacokinetics. : While disulfiram has promise as a "repurposed" agent in human disease, its risk profile is of concern. Animal studies and well-controlled clinical trials are needed to assess its safety and efficacy for non-alcohol-related indications.

摘要

自20世纪40年代发现双硫仑并经美国食品药品监督管理局(FDA)批准用于酒精使用障碍以来,人们对其其他适应症进行了研究。本综述描述了其潜在的临床应用、相关风险和挑战。

对于本叙述性综述,在PubMed上进行了文献检索,以查找涉及双硫仑体内研究的文章,重点是药物重新利用以治疗人类疾病。关键检索词为“双硫仑”和“戒酒硫”。还纳入了突出重要机制和安全问题的动物研究和体外研究。

总共选择了1948年至2022年期间涉及我们研究重点的196篇文献。除酒精使用障碍外,新出现的数据支持双硫仑在治疗其他成瘾(如可卡因)、感染(如金黄色葡萄球菌和伯氏疏螺旋体等细菌、病毒、寄生虫)、炎症性疾病、神经疾病和癌症方面的潜在作用。副作用从小到危及生命不等,较低剂量的风险较小。由于双硫仑药代动力学在个体间存在相当大的变异性,因此在人体使用时需要谨慎。

虽然双硫仑有望作为一种“重新利用”的药物用于人类疾病,但它的风险状况令人担忧。需要进行动物研究和严格控制的临床试验来评估其在非酒精相关适应症方面的安全性和有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34a9/10044060/b21bd4bb7595/antibiotics-12-00524-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验